Healthcare :: ValleyCare and UCSF work to enhance health services in tri-valley region
ValleyCare Health System and UCSF have signed a letter of intent to enhance health care services for women and children in the Tri-Valley region of the East Bay.
ValleyCare Health System and UCSF have signed a letter of intent to enhance health care services for women and children in the Tri-Valley region of the East Bay.
In support of the latest March of Dimes Newborn Screening Report Card, the American College of Medical Genetics (ACMG) strongly urges every state to require complete testing of all newborns for a ?core panel? of genetic and congenital conditions.
Hyperthermia, combined with chemotherapy, improves the chances of healing and survival of patients with low-lying, soft tissue sarcomas. At the Annual General Meeting of the American Society of Clinical Oncology in Chicago, the GSF scientist Professor Dr. Rolf D. Issels, presented the results of the first, randomized worldwide phase III study in which the effectiveness and superiority of the combined-therapy methods are proven, in comparison with results from chemotherapy alone.
The number of lymph nodes that contain evidence of cancer is the best predictor of the effectiveness of adding chemotherapy and radiation to a treatment plan prior to surgery in individuals with oesophageal cancer, according to a study published last month in the Annals of Surgery.
Individuals with scleroderma are living significantly longer today, compared with 30 years ago, and the physicians who treat this rare disease of connective tissue hope the newer drugs now on the market may extend lives even further.
Women who have suffered heart attacks have higher rates of lingering depressive symptoms compared to their male counterparts, a University of Alberta and McGill University study shows.
Many people don?t give their kidneys enough serious thought, according to Prabir Roy-Chaudhury, nephrologist at UC.
A genetically engineered herpes simplex virus, primarily known for causing cold sores, may help keep arteries ?free-flowing? in the weeks following angioplasty or stent placement for patients, according to research published early in the online edition of PNAS (Proceedings of the National Academy of Sciences of the United States of America).
A gene known as HDAC1 may be a good target for drugs to treat multidrug-resistant neuroblastoma, a cancer that develops in immature nerve cells and is prevalent in children.
A new targeted drug delivery method uses ultrasound to image tumors, while also releasing the drug from ?nanobubbles? into the tumor.